Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCSG-6a: Extended Adjuvant Anastrozole vs No Treatment
NCT00300508Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 1996
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of anastrozole in breast cancer, sponsored by AstraZeneca. Started Jan 1996; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00300508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300508.